Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Outset Medical Inc has a consensus price target of $8.21 based on the ratings of 8 analysts. The high is $17 issued by RBC Capital on November 11, 2025. The low is $3 issued by TD Cowen on August 8, 2024. The 3 most-recent analyst ratings were released by BTIG, Stifel, and BTIG on February 12, 2026, January 7, 2026, and December 16, 2025, respectively. With an average price target of $13.33 between BTIG, Stifel, and BTIG, there's an implied 276.65% upside for Outset Medical Inc from these most-recent analyst ratings.
1calculated from analyst ratings
| Buy Now | Get Alert | ||||||
|---|---|---|---|---|---|---|---|
| 02/12/2026 | Buy Now | 323.73% | BTIG | $17 → $15 | Maintains | Buy | Get Alert |
| 01/07/2026 | Buy Now | 125.99% | Stifel | $14 → $8 | Maintains | Buy | Get Alert |
| 12/16/2025 | Buy Now | 380.23% | BTIG | $17 → $17 | Reiterates | Buy → Buy | Get Alert |
| 11/11/2025 | Buy Now | 295.48% | Stifel | $17 → $14 | Maintains | Buy | Get Alert |
| 11/11/2025 | Buy Now | 380.23% | RBC Capital | $22 → $17 | Maintains | Sector Perform | Get Alert |
| 11/11/2025 | Buy Now | 380.23% | BTIG | $39 → $17 | Maintains | Buy | Get Alert |
| 08/19/2025 | Buy Now | 521.47% | RBC Capital | $22 → $22 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 08/07/2025 | Buy Now | 521.47% | RBC Capital | $21 → $22 | Maintains | Sector Perform | Get Alert |
| 05/21/2025 | Buy Now | 493.22% | RBC Capital | $14 → $21 | Maintains | Sector Perform | Get Alert |
| 05/08/2025 | Buy Now | 295.48% | RBC Capital | $12 → $14 | Maintains | Sector Perform | Get Alert |
| 01/07/2025 | Buy Now | -15.25% | RBC Capital | $3 → $3 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 08/08/2024 | Buy Now | -15.25% | RBC Capital | $6 → $3 | Downgrade | Outperform → Sector Perform | Get Alert |
| 08/08/2024 | Buy Now | -15.25% | TD Cowen | $9 → $3 | Maintains | Buy | Get Alert |
| 06/21/2024 | Buy Now | 69.49% | RBC Capital | $5 → $6 | Upgrade | Sector Perform → Outperform | Get Alert |
| 04/08/2024 | Buy Now | 69.49% | BTIG | → $6 | Initiates | → Buy | Get Alert |
| 01/12/2024 | Buy Now | 69.49% | RBC Capital | $14 → $6 | Downgrade | Outperform → Sector Perform | Get Alert |
| 12/04/2023 | Buy Now | 55.37% | Morgan Stanley | $5 → $5.5 | Maintains | Equal-Weight | Get Alert |
| 11/14/2023 | Buy Now | 41.24% | Morgan Stanley | $19 → $5 | Maintains | Equal-Weight | Get Alert |
| 10/13/2023 | Buy Now | 380.23% | RBC Capital | $29 → $17 | Maintains | Outperform | Get Alert |
| 10/13/2023 | Buy Now | 69.49% | Stifel | $26 → $6 | Maintains | Buy | Get Alert |
| 10/13/2023 | Buy Now | -15.25% | B of A Securities | $32 → $3 | Downgrade | Buy → Underperform | Get Alert |
| 08/24/2023 | Buy Now | 436.72% | Morgan Stanley | $22 → $19 | Maintains | Equal-Weight | Get Alert |
| 08/17/2023 | Buy Now | 719.21% | RBC Capital | → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 08/17/2023 | Buy Now | — | CL King | — | Initiates | → Neutral | Get Alert |
| 08/03/2023 | Buy Now | 521.47% | Morgan Stanley | $23 → $22 | Maintains | Equal-Weight | Get Alert |
| 05/31/2023 | Buy Now | 549.72% | Morgan Stanley | $27 → $23 | Maintains | Equal-Weight | Get Alert |
| 05/15/2023 | Buy Now | 719.21% | RBC Capital | → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 05/04/2023 | Buy Now | 719.21% | RBC Capital | $32 → $29 | Maintains | Outperform | Get Alert |
The latest price target for Outset Medical (NASDAQ:OM) was reported by BTIG on February 12, 2026. The analyst firm set a price target for $15.00 expecting OM to rise to within 12 months (a possible 323.73% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for Outset Medical (NASDAQ:OM) was provided by BTIG, and Outset Medical maintained their buy rating.
The last upgrade for Outset Medical Inc happened on June 21, 2024 when RBC Capital raised their price target to $6. RBC Capital previously had a sector perform for Outset Medical Inc.
The last downgrade for Outset Medical Inc happened on August 8, 2024 when RBC Capital changed their price target from $6 to $3 for Outset Medical Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Outset Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Outset Medical was filed on February 12, 2026 so you should expect the next rating to be made available sometime around February 12, 2027.
While ratings are subjective and will change, the latest Outset Medical (OM) rating was a maintained with a price target of $17.00 to $15.00. The current price Outset Medical (OM) is trading at is $3.54, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API
Market data provided by Benzinga APIs
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.